Artificial Pancreas: The First 20 Years.

作者信息

Doyle Francis J, Kovatchev Boris P

机构信息

School of Engineering, Brown University, Providence, RI, USA.

Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.

出版信息

J Diabetes Sci Technol. 2025 Jul;19(4):875-882. doi: 10.1177/19322968251330920. Epub 2025 Jul 1.

DOI:10.1177/19322968251330920

PMID:40590462

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12213539/

Abstract

摘要

相似文献

[1]

Artificial Pancreas: The First 20 Years.

J Diabetes Sci Technol. 2025-7

[2]

NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.

J Diabetes Sci Technol. 2024-1

[3]

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.

BMJ. 2018-4-18

[4]

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

Lancet Diabetes Endocrinol. 2017-5-19

[5]

IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.

JCI Insight. 2021-11-8

[6]

Early Stages of Automated Insulin Delivery.

J Diabetes Sci Technol. 2025-7

[7]

Early Stages of Automated Insulin Delivery.

Diabetes Technol Ther. 2025-7

[8]

Meeting Report: The Fourth Artificial Pancreas Workshop: Testing and Adoption of Current and Emerging Technologies.

J Diabetes Sci Technol. 2017-11

[9]

Commentary: Parallel evolution of Molecular Endocrinology as a journal and a discipline: convergence of interests with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH).

Mol Endocrinol. 2010-9

[10]

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.

Lancet Diabetes Endocrinol. 2015-6-8

本文引用的文献

[1]

Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP Systems.

J Diabetes Sci Technol. 2025-7

[2]

Real-Life Use of Automated Insulin Delivery in Individuals With Type 2 Diabetes.

J Diabetes Sci Technol. 2024-8-24

[3]

Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial.

Diabetes Technol Ther. 2024-11

[4]

Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.

Lancet Diabetes Endocrinol. 2024-6

[5]

Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.

Diabetes Technol Ther. 2024-9

[6]

Hybrid Closed Loop in Adults With Type 1 Diabetes and Severely Impaired Hypoglycemia Awareness.

J Diabetes Sci Technol. 2024-4-13

[7]

Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience.

Diabetes Technol Ther. 2024-3

[8]

Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes.

Diabetes Technol Ther. 2024-8

[9]

Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes.

Diabetes Technol Ther. 2024-7

[10]

Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence.

Diabetes Technol Ther. 2024-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Artificial Pancreas: The First 20 Years.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献